Illinois Pays $10.5M to Clean Up Radioactive Mess, Avoids Suit
Published Date: 7/21/2025
Notice
Summary
The State of Illinois has agreed to help clean up radiation contamination at a Superfund site in Ottawa by providing services worth about $10.5 million. In return, the U.S. government won’t sue the state over this issue. People have 30 days from July 21, 2025, to share their thoughts on this plan before it’s finalized.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Illinois to provide $10.49M for Ottawa cleanup
The State of Illinois agreed to provide in-kind services valued at about $10.49 million to support the U.S. EPA remedial action at the NPL-8 subarea of the Ottawa Radiation Areas Superfund Site in Ottawa, Illinois. In return, the United States will provide a covenant not to sue the State under sections 106 and 107 of the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-12143 — Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
AndersonBrecon, Inc. DBA PCI Pharma Services wants to become an official importer of certain controlled substances, including some strong drugs like tetrahydrocannabinols. People and companies involved with these drugs can share their thoughts or ask for a hearing by July 17, 2026. This move could impact how these substances are brought into the U.S., but no costs or fees were mentioned yet.
2026-12213 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement With Change to a Previously Approved Collection Title-International Terrorism Victim Expense Reimbursement Program Application
The Department of Justice is bringing back and updating the application form for the International Terrorism Victim Expense Reimbursement Program. This affects victims of international terrorism who seek help covering their expenses. The DOJ wants your feedback by July 17, 2026, to make sure the form is clear, useful, and easy to fill out—no extra hassle or hidden costs involved!
2026-12144 — Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
Wedgewood Pharmacy LLC wants to become an official importer of certain strong controlled substances, like Etorphine HCL and Thiafentanil. This affects drug manufacturers and others in the supply chain who can comment or request a hearing by July 17, 2026. No direct costs are mentioned, but the decision could impact how these drugs enter the U.S. market.
Previous / Next Documents
Previous: 2025-13659 — Mid-Atlantic Fishery Management Council (MAFMC); Public Meeting
The Mid-Atlantic Fishery Management Council is hosting a public meeting to talk about managing mackerel, squid, and butterfish. Fishermen, seafood businesses, and ocean lovers should tune in because decisions made here could change fishing rules and affect when and how much fish can be caught. The meeting is a chance to shape the future of these important sea critters and the money tied to their harvest.
Next: 2025-13662 — Application for Final Commitment for a Long-Term Loan or Financial Guarantee in Excess of $100 Million: AP300021XX
The Export-Import Bank of the United States got a big loan request over $100 million and wants to hear what the public thinks before making a final decision. This affects businesses and projects that might get this financial boost soon. If you have thoughts, now’s the time to share them before the bank’s board gives the green light!